Moreover, some OVs have been designed to express T cell costimulatory molecules, including CD40, 4-1BB, or OX40 (CD134), to stimulate tumor-specific T cell activation and strengthen anti-tumor immunity [100,101,102,103,104]. This evidence concerns the gene TNFRSF4 and neoplasm.